Healthcare professionals from across the haematology-oncology multidisciplinary team attended this educational meeting, to engage in discussion, debate and the sharing of clinical experience regarding the management of chronic lymphocytic leukaemia (CLL) patients.
Please see below for a summary of the meeting agenda.
Note: The educational content of this meeting is CPD® certified.
This is a non-promotional CLL educational meeting for UK haemato-oncology healthcare professionals, fully funded and organised by the AstraZeneca UK Medical Affairs team.
Speakers
Professor Christopher Fegan - Chair
Emeritus Professor of Haematology, University Hospital Cardiff, Cardiff
Professor Anna Schuh - Speaker
Honorary Consultant Haematologist, Churchill Hospital, Oxford
Dr Sarah Noakes - Speaker
Macmillan Counselling Psychologist, Imperial Healthcare NHS Trust, London
Dr Dima El-Sharkawi - Speaker
Consultant Haematologist, Royal Marsden Hospital, London
Ms Lenient Musangeya - Speaker
Lymphoma Clinical Nurse Specialist, Royal Marsden Hospital, London
Agenda
12:30—13:00
Registration and buffet Lunch (optional for in-person attendees)
13:00—13:15
Welcome, Introductions, and Objectives - Professor Christopher Fegan
13:15—14:15
Session 1: Update on CLL Diagnosis and Prognostic Markers in Clinical Practice - Professor Anna Schuh
- What are they, how are they relevant, why is it done, and how can it inform clinical decision making?
14:15—14.30
Break
14:30—15.30
Session 2: Psychological Support for CLL Patients - Dr Sarah Noakes
- What is the impact of diagnosis and watch and wait on patients?
- What practical strategies can be applied to understanding patient needs and communicating with patients?
15:30—16.30
Session 3: Broader Considerations in the Management of CLL - Dr Dima El-Sharkawi & Ms Lenient Musangeya
- The CLL patient journey from diagnosis to living with CLL
16:30—16.40
Conclusions and Closing Remarks - Professor Christopher Fegan
